--- title: Driving Innovation in Diabetes description: Profil Germany takes a holistic approach to serving the community of diabetes clinical researchers and driving innovation. --- [![profil-logo-wortbild-with claim-4c-offset_1000px](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px.png?width=250&name=profil-logo-wortbild-with%20claim-4c-offset_1000px.png "profil-logo-wortbild-with claim-4c-offset_1000px")](https://www.profil.com?hsLang=en-us) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) # [![Innovation Header](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x260px_About_Profil.jpg?width=1077&height=260&name=Header_1077x260px_About_Profil.jpg) Driving Innovation in Diabetes at Profil Discover how Profil supports innovation in diabetes research and treatment.](https://www.profil.com/organisation/driving-innovation-in-diabetes#) ## Support for innovative research As part of our commitment to improving the quality of life and healthcare of people with diabetes and other metabolic diseases, we support our clients to explore the full range of diabetes treatment and prevention innovations taking into account the high diversity of disease trigger and pathogenetic traits (Figure 1). ### Personalized healthcare for diabetes Combining molecular profiling with the consideration of an individual’s traits, goals and preferences may optimize the precision fit of measures for diabetes prevention and treatment. The identification of patient-specific diabetes signatures and polypharmacy profiles promotes the implementation of more personalized treatments. Comorbidity-adjusted diabetes care acknowledges the high diversity in functional reserves and cognitive performances—factors that critically determine self-management capabilities, treatment benefit and the likelihood of hospitalization. Profil has a large [methodological portfolio](https://www.profil.com/services/methods?hsLang=en-us) for anthropometric, metabolic and [cardiovascular assessments](https://www.profil.com/expertise/cardiometabolic-research?hsLang=en-us), and our clinical trials include careful monitoring of treatment effect modifiers, such as [dietary and physical activity](https://www.profil.com/services/exercise-energy-expenditure?hsLang=en-us) habits. Our database of [potential trial subjects](https://www.profil.com/services/patient-recruitment?hsLang=en-us) contains lifestyle and medical data and we are thus in regular contact with over 30,000 people representing the entire diversity of groups targeted by innovations in diabetes. We have benefitted greatly by listening to patients who have repeatedly participated in our studies. We are active with the Center for Biomarker Research in Medicine (CBmed), which puts us in the position to connect our integrated service portfolio with advanced “omics” analytical platforms and provides access to the largest European biobanks and a digital pathology platform.   ![Icon_NewWebinar.png](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_NewWebinar.png?width=62&height=70&name=Icon_NewWebinar.png) ### Online Seminar On-demand Online Seminar: **"EU-funded R&D** **partnerships for healthy** **living and active ageing"**   [![Watch now](https://no-cache.hubspot.com/cta/default/481167/d8daad02-d58e-48c3-a973-3375b77416c3.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/d8daad02-d58e-48c3-a973-3375b77416c3) ![Tim_Hexagon_154x176](https://www.profil.com/hs-fs/hubfs/Mitarbeiter/Tim_Hexagon_154x176.png?width=154&height=175&name=Tim_Hexagon_154x176.png) ### Our expert **Dr. Tim Heise** Lead Scientist [![Contact](https://no-cache.hubspot.com/cta/default/481167/96e42971-e647-4df5-9207-76510d17c7d1.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/96e42971-e647-4df5-9207-76510d17c7d1) ![Pikto_Testimonials](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Pikto_Testimonials.png?width=82&height=91&name=Pikto_Testimonials.png) ### "In Profil we found a partner, who can help us to define our needs in terms of study design and definition of target endpoints." **Cyril Seroussi, Clinical Operations Manager, Adocia** [![risk_factors_in_the_evolution_of_diabetes](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/content-bilder/Driving_Innovation/risk_factors_in_the_evolution_of_diabetes.jpg?width=250&height=204&name=risk_factors_in_the_evolution_of_diabetes.jpg) ![](http://jubilaeum.bluemoon.de/wp-content/themes/BLUE_MOON/tmpl-images/lupe.png) ](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Driving_Innovation/risk_factors_in_the_evolution_of_diabetes.jpg/medium.jpg?t=1440659617503&hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=en-us) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Stegbauer, C. et al. 2020. Costs and its drivers for diabetes mellitus type 2 patients in France and Germany: a systematic review of economic studies. BMC Health Serv Res. 2020 Nov 16;20(1):1043. [View all](https://www.profil.com/knowledge-center/publications?hsLang=en-us) Profil (or the Profil Institute for Metabolic Research) is deeply committed to providing the best support to those who wish to improve the treatment and quality of life of people with diabetes and other metabolic conditions. We support investigations that intend to find innovative and personalized ways to deal with diabetes and associated chronic diseases and comorbidities, including disability and frailty, particularly in light of the ageing populations and increase in diabetes incidence. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=en-us) | [Privacy Policy](https://www.profil.com/privacy?hsLang=en-us)